{"id":318963,"date":"2021-04-27T22:53:06","date_gmt":"2021-04-27T20:53:06","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=318963"},"modified":"2021-04-27T22:53:06","modified_gmt":"2021-04-27T20:53:06","slug":"fajzer-ispituje-lijek-protiv-kovid19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2021\/04\/27\/fajzer-ispituje-lijek-protiv-kovid19\/","title":{"rendered":"Fajzer ispituje lijek protiv Kovid19"},"content":{"rendered":"<p>Ameri\u010dka farmaceutska kompanija Fajzer trenutno sprovodi klini\u010dko ispitivanje eksperimentalnog lijeka pod nazivom PF-07321332, prve pilule kojom bi se izlije\u010dio Kovid-19.<\/p>\n<p>Ovaj lijek pripada klasi medikamenata pod nazivom inhibitori proteze, a antivirusna pilula trebalo bi da spre\u010dava \u0161irenje virusa u tijelu blokiranjem enzima koji koronavirus koristi za stvaranje svojih kopija u ljudskim \u0107elijama.<\/p>\n<p>\u201eDejli mejl\u201c prenosi da je planirano da prva faza klini\u010dkih ispitivanja u SAD i Belgiji bude zavr\u0161ena 25. maja, a ukoliko naredne faze koje treba da budu okon\u010dane do sredine jula doka\u017eu da je lijek uspe\u0161an, mogao bi biti dostupan u protokolima lije\u010denja ve\u0107 na jesen.<\/p>\n<p>Lijek, poznat kao PF-07321332, prepisivao bi se pacijentima kod pojave prvih znakova infekcije KOVID-19.<\/p>\n<p>Za sada nije poznato da li bilo koja ameri\u010dka vladina agencija finansira klini\u010dka ispitivanja i da li su SAD ve\u0107 uputile bilo kakve narud\u017ebine za ovaj lijek.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lijek, poznat kao PF-07321332, prepisivao bi se pacijentima kod pojave prvih znakova infekcije KOVID-19.<\/p>\n","protected":false},"author":1,"featured_media":318964,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-318963","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/318963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=318963"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/318963\/revisions"}],"predecessor-version":[{"id":318965,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/318963\/revisions\/318965"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/318964"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=318963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=318963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=318963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}